These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2801095)

  • 21. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survey of the use of tests for human papilloma virus and epidermal growth factor receptor for squamous cell carcinoma of the head and neck in UK head and neck multidisciplinary teams.
    Ahmed A; Cascarini L; Sandison A; Clarke P
    Br J Oral Maxillofac Surg; 2012 Mar; 50(2):119-21. PubMed ID: 21450378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
    Rubin Grandis J; Tweardy DJ; Melhem MF
    Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives of monoclonal antibodies for detection and treatment of head and neck tumours.
    Quak J; Gerretsen M; De Bree R; Brakenhof R; Van Dongen G; Snow G
    Anticancer Res; 1993; 13(6B):2533-9. PubMed ID: 8135493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
    Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C
    Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor receptor (EGFR) in oral squamous cell carcinomas: overexpression, localization and therapeutic implications.
    Kuttan NA; Bhakthan NM
    Indian J Dent Res; 1997; 8(1):9-18. PubMed ID: 9495132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
    Yacoub L; Goldman H; Odze RD
    Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of proliferating-cell nuclear antigen and epidermal growth factor receptor in intraepithelial squamous cell lesions of human bronchus.
    Yoneda K
    Mod Pathol; 1994 May; 7(4):480-6. PubMed ID: 7915034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
    Franchi A; Gallo O; Boddi V; Santucci M
    Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
    Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
    Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of tissue array technology in head and neck squamous cell carcinoma.
    Chen B; van den Brekel MW; Buschers W; Balm AJ; van Velthuysen ML
    Head Neck; 2003 Nov; 25(11):922-30. PubMed ID: 14603452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR.
    Hambek M; Baghi M; Strebhardt K; May A; Adunka O; Gstöttner W; Knecht R
    Anticancer Res; 2004; 24(6):3881-6. PubMed ID: 15736426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck.
    Gires O; Mack B; Rauch J; Matthias C
    Biochem Biophys Res Commun; 2006 Apr; 343(1):252-9. PubMed ID: 16540085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of an activation state marker for epidermal growth factor receptor in tissue microarrays of head and neck cancer.
    Kong A; Leboucher P; Leek R; Calleja V; Winter S; Harris A; Parker PJ; Larijani B
    Cancer Res; 2006 Mar; 66(5):2834-43. PubMed ID: 16510606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tumor-associated macrophages (TAM) in the stroma of squamous cell carcinomas of the ENT area studied using monoclonal antibodies].
    Bettinger R; Knecht R; Lörz M; von Ilberg C
    Laryngorhinootologie; 1990 Dec; 69(12):631-5. PubMed ID: 2288626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A statistical analysis of the results obtained with anti-PCNA/cyclin monoclonal antibody in pulmonary epidermoid carcinomas].
    Niţă M; Gasser B
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):423-7. PubMed ID: 7908749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine differentiation in head and neck squamous cell carcinoma.
    Schartinger VH; Falkeis C; Laimer K; Sprinzl GM; Riechelmann H; Rasse M; Virgolini I; Dudás J
    J Laryngol Otol; 2012 Dec; 126(12):1261-70. PubMed ID: 23050666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoma-associated monoclonal antibodies in head and neck carcinoma. Immunohistochemistry and biodistribution of monoclonal antibodies 175F4 and 175F11.
    Balm AJ; Hageman PC; Mulder CL; Hilkens J
    Eur Arch Otorhinolaryngol; 1992; 249(5):237-42. PubMed ID: 1524802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.